Table 2.
NCT | Phase | Cells | Route | Dose | Age | Target Enroll-ment | Country |
---|---|---|---|---|---|---|---|
NCT04062136 | I | UC-MSCs | Iv | 1 × 10^6/kg × 2 | 1–6 months | 10 | Vietnam |
NCT03558334 | I | UC-MSCs | Iv | 1 × 10^6/kg 5 × 10^6/kg |
nk | 12 | China |
NCT03601416 | II | UC-MSCs | Iv | 1 × 10^6/kg 5 × 10^6/kg |
up to 1 year | 57 | China |
NCT03645525 | I–II | UC-MSCs | It | 2 × 10^7/kg | up to 3 weeks | 180 | China |
NCT03378063 | I | UCB-MSCs | Nk | Nk | 1–3 months | 100 | China |
NCT02443961 | I | MSCs (not spec) | Nk | 5 × 10^6/kg × 3 | 1 month to 28 weeks | 10 | Spain |
NCT03683953 | I | MSCs (not spec) | It | 25 × 10^6/kg | 28 to 37 WG | 200 | China |
NCT03631420 | I | UC-MSCs | Nk | 3 × 10^6/kg 10 × 10^6/kg 30 × 10^6/kg |
36–38 WG | 9 | Taiwan |
NCT03774537 | I–II | UC-MSCs | Iv | 1 × 10^6/kg 5 × 10^6/kg |
3–14 days | 20 | China |
NCT01207869 | I | UC-MSCs | It | 3 × 10^6/kg | up to 6 months | 10 | Taiwan |
NCT02381366 | I–II | UCB-MSCs | Nk | 10 × 10^6/kg 20 × 10^6/kg |
up to 14 days | 12 | Illinois–USA |
NCT01297205 | I | UCB-MSCs | It | 10 × 10^6/kg 20 × 10^6/kg |
up to 14 days | 9 | Republic of Korea |
NCT01828957 | II | UCB-MSCs | It | 10 × 10^6/kg | up to 14 days | 69 | Republic of Korea |
NCT03392467 | II | UCB-MSCs | Nk | Nk | up to 13 days | 60 | Republic of Korea |
NCT04255147 | I | UC-MSCs | Iv | 1 × 10^6/kg 3 × 10^6/kg 10 × 10^6/kg |
7–21 days | 9 | Ontario–Canada |
Abbreviations: UC: umbilical cord; UCB: umbilical cord blood; MSCs: mesenchymal stem cells; iv: intravenous; it: intratracheal; nk: not known; WG: weeks of gestation.